Carisma Therapeutics Inc.

Ownership Transactions Reported by 27 Insiders

Symbol
CARM on Nasdaq
Industry
Pharmaceutical Preparations
Location
3675 Market Street, Suite 200, Philadelphia, PA

There are no Buy or Sell transactions made by insiders since 12/22/2023

Carisma Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ModernaTX, Inc. 10%+ Owner $2.97M Mar 7, 2023
Regina Hodits Director $1.35M Mar 7, 2023
Thomas R. Cannell President and CEO, Director $395K Mar 2, 2023
Minori Rosales Chief Development Officer $366K Jan 24, 2022
Monica Forbes Chief Financial Officer $297K Mar 2, 2023
Glen C. MacDonald Chief Technology Officer $234K Mar 2, 2023
Mark Sullivan General Counsel & Secretary $222K Mar 2, 2023
Elly Ryu Principal Accounting Officer $87.2K Mar 2, 2023
Peter Honig Director $23.5K Jun 22, 2022
Carrie L. Bourdow Director $23.5K Jun 22, 2022
A. Jewett Michael Director $23.5K Jun 22, 2022
Jason A. Keyes Director $23.5K Jun 22, 2022
Jay S. Duker Director $23.5K Jun 22, 2022
Bjorn Odlander Director Mar 7, 2023
David Scadden Director Jul 1, 2024
Marella Thorell Director Jul 1, 2024
Sohanya Cheng Director Oct 31, 2024
Steven Kelly President and CEO, Director Jun 17, 2024
Briggs Morrison Director Jun 26, 2024
Michael Klichinsky Chief Scientific Officer Jun 17, 2024
Michael Torok Director Jun 26, 2024
Chidozie Ugwumba Director Jun 6, 2023
Sanford Zweifach Director Jun 26, 2024
Richard Morris Chief Financial Officer Jun 17, 2024
John Hohneker Director Jun 26, 2024
Jane Henderson Director May 3, 2021
Patricia M. Drake Chief Commercial Officer Jun 1, 2021

Recent Insider Transactions by Companies or Individuals for Carisma Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.